Clinical trials
Phase 2 Lymphoma trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 4 |
| ADC Therapeutics S.A. | 2 |
| Amgen | 2 |
| Celgene | 2 |
| AstraZeneca | 1 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 1 |
| Hoffmann-La Roche | 1 |
| Janssen Research & Development, LLC | 1 |
| MedImmune LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 21 |
| Lymphoma, Non-Hodgkin | 7 |
| Lymphoma, Follicular | 5 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Hodgkin Disease | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Multiple Myeloma | 2 |
| Neoplasm Metastasis | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.